<DOC>
	<DOCNO>NCT00495898</DOCNO>
	<brief_summary>The main objective study assess safety effectiveness CYPHER sirolimus-eluting stent maintain minimum lumen diameter de novo native coronary artery lesion compare uncoated Bx VELOCITY balloon-expandable stent patient manifest diabetes mellitus . Both stent mount Raptorâ Rapid Exchange Stent Delivery System .</brief_summary>
	<brief_title>A Study Diabetic Patients With De Novo Native Coronary Artery Lesions</brief_title>
	<detailed_description>This multicenter ( 19 site ) , prospective , 2 arm randomize study design ass safety effectiveness CYPHER sirolimus-eluting stent compare uncoated Bx VELOCITY balloon-expandable stent patient manifest diabetes mellitus . Patients de novo native coronary artery lesion &lt; = 42 mm length &gt; =2.5mm &lt; =3.5mm diameter ( visual estimate ) include study . A total 190 patient enter randomly allocate CYPHERTM sirolimus-eluting stent uncoated Bx VELOCITY balloon-expandable stent 1:1 ratio . Patients follow 12 month post-procedure , patient repeat angiography 8 month ( ± 1 month ) . It anticipate total duration study 18 month : 6 month complete patient enrollment 12 month follow .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Diagnosis angina pectoris define Canadian Cardiovascular Society Classification ( CCS I , II , III , IV ) OR unstable angina pectoris ( Braunwald Classification B III ) OR patient document silent ischemia ; Manifest diabetes mellitus , proven fast glucose ( 12 h ) &gt; 127 mg/dl oral glucose challenge : &gt; = 200 mg/dl 2 h diabetes mellitus already treat oral antidiabetic insulin ; Treatment de novo native coronary artery lesion major coronary artery patient single multivessel disease ; patient 2 morevesseldisease enrol previous treatment ( ) lesion target lesion take place least 3 month prior enrolment study . If 1 study stent necessary treat lesion , overlap strongly recommend ; Target vessel diameter lesion site &gt; = 2.5mm &lt; = 3.5mm ( visual estimate ) ; ( stent available 2.5 / 3.0 mm width ) ; Target lesion &lt; = 42mm length ( visual estimate ) ; ( stent available 8 , 18 33 mm length ) ; Target lesion diameter stenosis &gt; 50 % &lt; 100 % ( visual estimate ) ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>